RG
FDMT icon

Redmile Group’s 4D Molecular Therapeutics FDMT Stock Holding History

Redmile Group’s Portfolio FDMT Stock Details FDMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-112,168
Closed -$416K – 43
2025
Q2 		$416K Sell
112,168
-885,067
-89% -$3.11M 0.04% 47
2025
Q1 		$3.22M Sell
997,235
-199,675
-17% -$941K 0.3% 44
2024
Q4 		$6.67M Sell
1,196,910
-65,180
-5% -$512K 0.46% 41
2024
Q3 		$13.6M Buy
1,262,090
+188,655
+18% +$3.13M 0.8% 33
2024
Q2 		$22.5M Sell
1,073,435
-187,992
-15% -$4.72M 1.36% 29
2024
Q1 		$40.2M Buy
+1,261,427
New +$32.2M 1.48% 25

Other funds holding FDMT

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
AC
Armistice Capital New York $3.03B AUM 36.06% 1-Year Est. Return